Newsletter | April 16, 2025

04.16.25 -- Advancing Bioprocessing Solutions

Embracing Sustainability And Digital Advancements In Biopharmaceuticals

The next pharmaceutical breakthroughs will be defined by a dual push: minimizing environmental footprint and maximizing digital efficiency. This article examines how industry leaders are navigating new regulations while embracing advanced data-driven solutions. Read the full article now.

 

Powering Sustainability In Pharma

This e-book offers a comprehensive exploration of how innovative practices and solutions can transform your operations while protecting resources vital to life. Examine best practices, real-world examples, and industry insights on enhancing productivity and ensuring regulatory compliance, while maintaining the highest standards of quality. Download your free copy of the e-book.

 

Offering Cost-Effective Solutions To Biosimilar Development

Drug developers face a significant challenge in controlling production costs while achieving the high standards of efficacy and similarity required of biosimilars. In this webinar, learn key insights into efficient biosimilar production that reveal how advanced purification technologies can reduce costs and meet stringent regulatory demands in today's market. Watch this useful webinar on demand.

 

SOLUTIONS

Discover How Resilience Is Benefitting From Innovative Chromatography Resins And Technical Support

Review the latest case study highlighting the collaboration between Ecolab® and Resilience CDMO in advancing biomanufacturing. Discover how Ecolab’s innovative Purolite™ Resins helped Resilience improve monoclonal antibody purification, resulting in high yields, fast scale-up, and a quicker route to market. Learn more about this impactful partnership in the full article.

• Request Information

 

 

 

Maximize Productivity And Efficiency With DurA™ Cycle

In this video, Renato Azevedo, Ecolab's Director Global Product Management for Bioprocessing, discusses the latest advancements in pharmaceutical manufacturing aimed at reducing bioburden through more intense cleaning regimes. Traditional protein A resins often struggle under these conditions, but DurA™ Cycle A50 is engineered for caustic resistance, enabling the use of half molar CIP protocols and significantly reducing microbial contamination. Watch the video to hear more.

• Request Information